questionsmedicales.fr
Techniques d'investigation
Techniques de laboratoire clinique
Techniques microbiologiques
Techniques bactériologiques
Techniques bactériologiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Programmed Cell Death 1 Receptor
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Techniques bactériologiques : Questions médicales les plus fréquentes",
"headline": "Techniques bactériologiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Techniques bactériologiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-01",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Techniques bactériologiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques microbiologiques",
"url": "https://questionsmedicales.fr/mesh/D008828",
"about": {
"@type": "MedicalCondition",
"name": "Techniques microbiologiques",
"code": {
"@type": "MedicalCode",
"code": "D008828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Techniques de typage bactérien",
"alternateName": "Bacterial Typing Techniques",
"url": "https://questionsmedicales.fr/mesh/D015373",
"about": {
"@type": "MedicalCondition",
"name": "Techniques de typage bactérien",
"code": {
"@type": "MedicalCode",
"code": "D015373",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875.150.125"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lysotypie",
"alternateName": "Bacteriophage Typing",
"url": "https://questionsmedicales.fr/mesh/D001434",
"about": {
"@type": "MedicalCondition",
"name": "Lysotypie",
"code": {
"@type": "MedicalCode",
"code": "D001434",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875.150.125.150"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Test LAL",
"alternateName": "Limulus Test",
"url": "https://questionsmedicales.fr/mesh/D008033",
"about": {
"@type": "MedicalCondition",
"name": "Test LAL",
"code": {
"@type": "MedicalCode",
"code": "D008033",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875.150.570"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Techniques bactériologiques",
"alternateName": "Bacteriological Techniques",
"code": {
"@type": "MedicalCode",
"code": "D001431",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "A Yu Mironov",
"url": "https://questionsmedicales.fr/author/A%20Yu%20Mironov",
"affiliation": {
"@type": "Organization",
"name": "G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology."
}
},
{
"@type": "Person",
"name": "O Yu Borisova",
"url": "https://questionsmedicales.fr/author/O%20Yu%20Borisova",
"affiliation": {
"@type": "Organization",
"name": "G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology."
}
},
{
"@type": "Person",
"name": "N T Gadua",
"url": "https://questionsmedicales.fr/author/N%20T%20Gadua",
"affiliation": {
"@type": "Organization",
"name": "G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology."
}
},
{
"@type": "Person",
"name": "A S Pimenova",
"url": "https://questionsmedicales.fr/author/A%20S%20Pimenova",
"affiliation": {
"@type": "Organization",
"name": "G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology."
}
},
{
"@type": "Person",
"name": "S S Afanasiev",
"url": "https://questionsmedicales.fr/author/S%20S%20Afanasiev",
"affiliation": {
"@type": "Organization",
"name": "G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Programmed cell death-1 blockade therapy in melanoma: Resistance mechanisms and combination strategies.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36645031",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/exd.14750"
}
},
{
"@type": "ScholarlyArticle",
"name": "MicroRNAs Targeting Programmed Cell Death Protein 1 (PD-1) Promote Natural Killer Cell Exhaustion in Rheumatoid Arthritis.",
"datePublished": "2022-12-24",
"url": "https://questionsmedicales.fr/article/36640056",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18502/ijaai.v21i6.11524"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy.",
"datePublished": "2023-04-21",
"url": "https://questionsmedicales.fr/article/37153623",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1138145"
}
},
{
"@type": "ScholarlyArticle",
"name": "A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/35758515",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2340/actadv.v102.1062"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36442821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.actbio.2022.11.043"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de laboratoire clinique",
"item": "https://questionsmedicales.fr/mesh/D019411"
},
{
"@type": "ListItem",
"position": 4,
"name": "Techniques microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008828"
},
{
"@type": "ListItem",
"position": 5,
"name": "Techniques bactériologiques",
"item": "https://questionsmedicales.fr/mesh/D001431"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Techniques bactériologiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Techniques bactériologiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Techniques bactériologiques",
"description": "Comment se fait l'isolement des bactéries ?\nQu'est-ce qu'un test de sensibilité aux antibiotiques ?\nQuels milieux sont utilisés pour la culture bactérienne ?\nComment identifier une bactérie pathogène ?\nQu'est-ce qu'une coloration de Gram ?",
"url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Techniques bactériologiques",
"description": "Quels symptômes indiquent une infection bactérienne ?\nComment reconnaître une septicémie ?\nQuels signes d'infection cutanée bactérienne ?\nQuels symptômes d'une pneumonie bactérienne ?\nQuels symptômes d'une infection urinaire ?",
"url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Techniques bactériologiques",
"description": "Comment prévenir les infections bactériennes ?\nQuel rôle des vaccins dans la prévention ?\nPourquoi l'hygiène des mains est-elle importante ?\nComment éviter les infections nosocomiales ?\nQuel est l'impact de l'alimentation sur les infections ?",
"url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Techniques bactériologiques",
"description": "Quels antibiotiques sont couramment utilisés ?\nComment se déroule un traitement antibiotique ?\nQu'est-ce que la thérapie combinée ?\nComment traiter une infection cutanée ?\nQuelles sont les alternatives aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Techniques bactériologiques",
"description": "Quelles sont les complications d'une infection non traitée ?\nQuels risques d'une résistance aux antibiotiques ?\nComment une infection peut-elle affecter le cœur ?\nQuelles complications d'une pneumonie bactérienne ?\nQuels effets d'une infection sur le système nerveux ?",
"url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Techniques bactériologiques",
"description": "Quels sont les facteurs de risque d'infections bactériennes ?\nComment le tabagisme influence-t-il les infections ?\nQuel impact du diabète sur les infections ?\nPourquoi les personnes âgées sont-elles à risque ?\nQuel rôle joue l'hygiène dans le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se fait l'isolement des bactéries ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement se fait par culture sur milieux spécifiques pour favoriser la croissance."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un test de sensibilité aux antibiotiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un test qui détermine l'efficacité d'antibiotiques sur des bactéries isolées."
}
},
{
"@type": "Question",
"name": "Quels milieux sont utilisés pour la culture bactérienne ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des milieux comme le milieu nutritif, le milieu de MacConkey ou le milieu de Sabouraud."
}
},
{
"@type": "Question",
"name": "Comment identifier une bactérie pathogène ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des tests biochimiques, des colorations et des techniques moléculaires."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une coloration de Gram ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une méthode de coloration qui permet de classer les bactéries en Gram positif ou négatif."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection bactérienne ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, rougeur, gonflement et parfois écoulement purulent."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une septicémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par une fièvre élevée, des frissons, une fréquence cardiaque rapide et confusion."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection cutanée bactérienne ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, douleur, gonflement et parfois formation de pus."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une pneumonie bactérienne ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Toux, fièvre, douleurs thoraciques et difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection urinaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Brûlures à la miction, besoin fréquent d'uriner et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections bactériennes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par une bonne hygiène, vaccination et évitement des contacts avec des malades."
}
},
{
"@type": "Question",
"name": "Quel rôle des vaccins dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins stimulent le système immunitaire pour prévenir certaines infections bactériennes."
}
},
{
"@type": "Question",
"name": "Pourquoi l'hygiène des mains est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle réduit la transmission des bactéries et prévient les infections."
}
},
{
"@type": "Question",
"name": "Comment éviter les infections nosocomiales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des protocoles stricts d'hygiène et de désinfection dans les établissements de santé."
}
},
{
"@type": "Question",
"name": "Quel est l'impact de l'alimentation sur les infections ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée renforce le système immunitaire et aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quels antibiotiques sont couramment utilisés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pénicillines, céphalosporines, macrolides et fluoroquinolones."
}
},
{
"@type": "Question",
"name": "Comment se déroule un traitement antibiotique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il doit être prescrit par un médecin et suivi jusqu'à la fin pour éviter la résistance."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie combinée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisation de plusieurs antibiotiques pour traiter des infections complexes."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection cutanée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des antibiotiques topiques ou oraux selon la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives aux antibiotiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Probiotiques, phagothérapie et traitements immunomodulateurs."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'une infection non traitée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Septicémie, choc septique, et défaillance d'organes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques d'une résistance aux antibiotiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections plus difficiles à traiter, augmentation de la morbidité et mortalité."
}
},
{
"@type": "Question",
"name": "Comment une infection peut-elle affecter le cœur ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer une endocardite, une inflammation des valves cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une pneumonie bactérienne ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Abcès pulmonaire, pleurésie et détresse respiratoire aiguë."
}
},
{
"@type": "Question",
"name": "Quels effets d'une infection sur le système nerveux ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des méningites ou des encéphalites, avec des conséquences graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infections bactériennes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, immunodépression, diabète et hospitalisation prolongée."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme influence-t-il les infections ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il affaiblit le système immunitaire et augmente le risque d'infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quel impact du diabète sur les infections ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète augmente le risque d'infections cutanées et urinaires en raison de l'immunité affaiblie."
}
},
{
"@type": "Question",
"name": "Pourquoi les personnes âgées sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Leur système immunitaire est souvent affaibli, rendant les infections plus probables."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hygiène dans le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise hygiène augmente le risque de transmission des bactéries pathogènes."
}
}
]
}
]
}
Melanoma is a highly aggressive tumor derived from melanocytes. In recent years, the incidence and mortality of melanoma have gradually increased, seriously threatening human health. Classic treatment...
Natural killer (NK) cells play a role in the pathogenesis of rheumatoid arthritis (RA). Upregulated levels of programmed cell death protein 1 (PD-1) is a sign of exhausted NK cells that could be regul...
Leprosy is a chronic bacterial disease caused by...
Erythroderma is challenging to diagnose. The aim of this single-centre retrospective study was to identify factors that can be used to improve the diagnosis of erythroderma. Among 91 patients with ery...
Immune checkpoint blockade therapy targeting programmed death-1 (PD-1) or its major ligand programmed death-ligand 1 (PD-L1) has achieved remarkable success in the treatment of several tumors, includi...
The immune system uses various immune checkpoint axes to adjust responses, support homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung carcinoma (NSCLC) can use ...
Pembrolizumab or nivolumab plus chemotherapy was approved as a first-line treatment for high programmed cell death ligand 1 (PD-L1)-expressing esophageal squamous cell carcinoma (ESCC) by the European...
Post hoc analysis of the Chinese JUPITER-06 study focusing on efficacy stratified by PD-L1 tumor proportion score (TPS; using JS311 antibody) was conducted. Electronic databases were searched to ident...
The post hoc analysis of JUPITER-06 showed more prominent clinical benefit with PD-1 antibody plus chemotherapy than with chemotherapy alone in both the high and low PD-L1-expressing subgroups. Five r...
This study provided novel evidence supporting the superiority of PD-1 antibody plus chemotherapy to chemotherapy alone in patients with advanced ESCC with low PD-L1 expression. Further studies of pred...
Major depression (MD) may be associated with inflammation and immunity. PD-1 (programmed death-1), PD-L1 (programmed death-ligand 1) and PD-L2 (programmed death-ligand 2) are among the inhibitory immu...
During a period of 2 years, patients with MD and healthy controls were recruited from a medical centre in this study. The diagnosis of MD was established according to the DSM-5 criteria. The severity ...
A total of 54 patients with MD and 38 healthy controls were recruited. According to the analyses, there is a significantly higher PD-L2 level in MD than in healthy controls and lower PD-1 level after ...
It was found that PD-1 pathway might play an important role in MD. We need a large sample to prove these results in the future....
Tumor-infiltrating lymphocytes are detectable in up to 75% of triple-negative breast cancer. The composition of these infiltrates may influence prognosis and is not known regarding regulatory or effec...
This was a retrospective observational study. Clinical and pathological data from 38 triple-negative breast cancer patients treated with neoadjuvant chemotherapy at the University Hospital (HUCFF/UFRJ...
Statistically significant changes in stromal tumor-infiltrating lymphocyte categories were observed before and post-neoadjuvant chemotherapy, with 32% of intermediate cases becoming high. The correlat...
In this study, we observed that chemotherapy significantly increases stromal tumor-infiltrating lymphocytes, CD8 T cells, as well as CD8/FoxP3 ratio. Most importantly, programmed cell death protein 1 ...
Melanoma is widely treated with programmed cell death-1 (PD-1) inhibitors. As part of their anti-tumor immunity effect, they increase the susceptibility to cutaneous immune-related adverse events (cIR...